Discussing Recent Developments in Endometrial Cancer Presented at SGO and ASCO 2023 - European Medical Journal

Discussing Recent Developments in Endometrial Cancer Presented at SGO and ASCO 2023

Oncology

The EMJ Podcast | Bonus Episode

Exploring the most important developments in the field of endometrial cancer, this podcast episode features two highly esteemed guests: Bradley Monk, University of Arizona College of Medicine – Tucson, USA, and Creighton University School of Medicine, Omaha, Nebraska, USA; and Robert Coleman, Chief Medical Officer, Vaniam Group, Chicago, Illinois, USA. The experts offer their perspectives on recent information presented at the Society of Gynecologic Oncology (SGO) and American Society of Clinical Oncology (ASCO) annual meetings.

Spotify | Apple | Amazon MusicDownload MP3 (mp3, 47:30 mins)

 

Discussing the most common gynaecological malignancy in developed countries, this episode investigates the challenges associated with disease diagnosis, staging, stratification, and treatment. The discussions in this podcast cover the complexities of endometrial cancer, standard of care biomarkers, and efforts to personalise treatment. The experts also deliver an update on the important ongoing clinical trials that created a real buzz at both congresses.

This podcast was funded by a medical educational grant from GSK, with the purpose of enhancing the fundamental understanding of oncology specialists of key data and the latest advancements in endometrial cancer care.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.